Skip to main content
BEONE MEDICINES LTD. logo

BEONE MEDICINES LTD. — Investor Relations & Filings

Ticker · 688235 ISIN · CNE100005XT6 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 728 across all filing types
Latest filing 2021-11-30 Capital/Financing Update
Country CN China
Listing Shanghai Stock Exchange 688235

About BEONE MEDICINES LTD.

https://beonemedicines.com/

BEONE MEDICINES LTD. is a biopharmaceutical company focused on the research, development, and commercialization of innovative therapeutic solutions, primarily in the field of oncology. The company specializes in the discovery of targeted small molecule drugs and biologics designed to address unmet medical needs in cancer treatment. Its research and development pipeline emphasizes precision medicine, utilizing advanced molecular biology and medicinal chemistry platforms to identify novel drug candidates. BEONE MEDICINES LTD. aims to improve patient outcomes by developing high-efficacy, low-toxicity therapies that target specific genetic drivers of disease. The company maintains a strong focus on clinical-stage development and strategic collaborations to advance its portfolio of next-generation medicines.

Recent filings

Filing Released Lang Actions
百济神州首次公开发行股票并在科创板上市发行公告
Capital/Financing Update Classification · 100% confidence The document is a detailed announcement regarding the initial public offering (IPO) of Baiji Shenzhou Co., Ltd. on the Shanghai Stock Exchange's STAR Market (科创板). It includes extensive information about the issuance, pricing, underwriting, investor participation, strategic placement, and regulatory approvals from the China Securities Regulatory Commission (CSRC). The document contains detailed data on the number of shares issued, pricing methodology, investor categories, underwriting syndicate, and the timetable for the offering and related disclosures. It is not a financial report like an annual or interim report, nor is it a transcript, audit report, or management report. It is a comprehensive issuance announcement related to capital raising and financing activities. Therefore, the document best fits the category of Capital/Financing Update (CAP). The document length (15,000 characters) and content confirm it is a full announcement, not a brief notice or a report publication announcement.
2021-11-30 Chinese
中金公司、高盛高华、摩根大通、中信证券、国泰君安关于百济神州首次公开发行股票并在科创板上市之战略投资者的专项核查报告
Capital/Financing Update Classification · 95% confidence The document is a detailed report related to the special verification of strategic investors for the initial public offering (IPO) and listing of BeiGene Ltd. on the STAR Market (科创板) in China. It includes extensive information about the strategic investors, their qualifications, legal compliance, investment backgrounds, and related regulatory approvals. The document references specific regulatory approvals from the China Securities Regulatory Commission (CSRC) and the Shanghai Stock Exchange, and it is dated November 2021. The content is focused on the verification and qualification of strategic investors for the IPO, which is a specialized report related to the capital raising and listing process. This type of document is not a general annual report, earnings release, or management discussion, but rather a detailed capital/financing update related to the IPO process and strategic investor verification. Therefore, the most appropriate classification is Capital/Financing Update (CAP). The document length (15,000 characters) and detailed content confirm it is the report itself, not just an announcement or certification.
2021-11-30 Chinese
百济神州首次公开发行股票并在科创板上市投资风险特别公告
Capital/Financing Update Classification · 100% confidence The document is a detailed announcement regarding the initial public offering (IPO) of Baiji Shenzhou Co., Ltd. on the STAR Market (科创板) of the Shanghai Stock Exchange. It includes information about the underwriting syndicate, issuance size, pricing, allocation methods, lock-up periods, and risk disclosures related to the IPO. The document discusses the offering price, number of shares, over-allotment (green shoe) option, subscription procedures, and regulatory approvals. It is not a financial report like an annual or interim report, nor is it a transcript, audit report, or management report. It is also not a simple announcement of a report publication but a substantive disclosure about a capital raising event. Therefore, the document fits best under the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities such as IPOs.
2021-11-30 Chinese
北京市海问律师事务所关于百济神州有限公司战略投资者专项核查的法律意见书
Regulatory Filings Classification · 95% confidence The document is a legal opinion letter issued by a law firm regarding BeiGene, Ltd.'s initial public offering (IPO) and listing on the Shanghai Stock Exchange's STAR Market. It focuses on the verification of strategic investors' qualifications for the IPO. The document includes detailed legal and regulatory references, investor descriptions, and compliance checks related to the IPO process. It is not a financial report, earnings release, or management discussion, but a legal opinion related to a capital market transaction. This type of document is best classified under Regulatory Filings (RNS) as it is a regulatory compliance document and legal opinion associated with the IPO process, not a direct financial or management report.
2021-11-30 Chinese
百济神州首次公开发行股票并在科创板上市网上路演公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the initial public offering (IPO) of Baiji Shenzhou Co., Ltd. on the STAR Market, including details about the underwriting syndicate, issuance structure, and an online roadshow event. It does not contain financial statements or detailed financial performance data but rather provides information about the offering process and invites investors to participate in the roadshow. The document length is short (1874 characters) and serves as a notice or announcement rather than a full report. Therefore, it fits best into the category of Capital/Financing Update (CAP), which covers updates on company fundraising and financing activities such as IPOs.
2021-11-29 Chinese
百济神州首次公开发行股票并在科创板上市发行安排及初步询价公告
Capital/Financing Update Classification · 100% confidence The document is a detailed announcement regarding the initial public offering (IPO) of Baiji Shenzhou Co., Ltd. on the STAR Market (科创板) of the Shanghai Stock Exchange. It includes extensive information about the issuance arrangement, underwriting, pricing, strategic placement, investor qualifications, timetable, and other IPO-related details. The document references regulatory approvals from the China Securities Regulatory Commission and Shanghai Stock Exchange rules, and it is clearly an IPO issuance and offering announcement. It is not a financial report, earnings release, or management discussion, nor is it a voting result or a proxy statement. It is a capital market transaction update focused on the company's capital raising and share issuance. Therefore, the appropriate classification is Capital/Financing Update (CAP). The document length and detail confirm it is not a mere announcement of a report (RPA) or a regulatory filing (RNS).
2021-11-23 Chinese

Browse filings by year

6 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.